نتائج البحث - "pituitary carcinoma"

1

Should pituitary carcinoma be treated using a NET‐like approach? A case of complete remission of a metastatic malignant prolactinoma with multimodal therapy including immunotherapy

المؤلفون: Georges Noël, Alessio Imperiale, Bernard Goichot, Philippe Baltzinger, Seyid Baloglu, Marie-Caroline Taquet, Gabriel G. Malouf, Marine Gravaud

المصدر: Clinical Endocrinology. 98:633-637

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Pituitary macroadenoma, business.industry, Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, Complete remission, Multimodal therapy, Immunotherapy, Pituitary Irradiation, medicine.disease, Endocrinology, Malignant Prolactinoma, Internal medicine, Pituitary carcinoma, medicine, business, Prolactinoma

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68e5970f38b05b01b2fc041f2ae2ae19Test
https://doi.org/10.1111/cen.14645Test

2

Immune checkpoint inhibitor therapy for ACTH-secreting pituitary carcinoma: a new emerging treatment?

المؤلفون: Bastiaan Sol, Sandrine Aspeslagh, Gil Awada, Jeroen de Filette, Bart Neyns, Steven Raeymaeckers, Brigitte Velkeniers, Corina Andreescu

المساهمون: Internal Medicine, Rheumatology, Faculty of Medicine and Pharmacy, Clinical sciences, Basic (bio-) Medical Sciences, Radiology, Medical Oncology, Laboratory for Medical and Molecular Oncology, Laboratory of Molecullar and Cellular Therapy

المصدر: European Journal of Endocrinology

مصطلحات موضوعية: Adenoma, Adult, Male, medicine.medical_specialty, Side effect, Hypophysitis, Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, Somatic hypermutation, 030209 endocrinology & metabolism, Ipilimumab, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, Endocrinology, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Internal Medicine, medicine, Humans, Immune Checkpoint Inhibitor Therapy, Chemotherapy, Temozolomide, business.industry, Brief Report, Carcinoma, Cell Cycle Checkpoints, General Medicine, ACTH-Secreting Pituitary Carcinoma, medicine.disease, Treatment, ACTH-Secreting Pituitary Adenoma, Nivolumab, Radiology Nuclear Medicine and imaging, 030220 oncology & carcinogenesis, oncology, Pituitary carcinoma, Cancer research, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b61c3418778499c136483d38e98c061eTest
https://doi.org/10.1530/eje-20-0151Test

3

Aggressive pituitary adenoma in the context of Lynch syndrome: a case report and literature review on this rare coincidence

المؤلفون: Andreas Unterberg, Stefan Hähnel, Christopher Beynon, David E. Reuss, Annekathrin Reinhardt, Jan Teuber

المصدر: British Journal of Neurosurgery. :1-6

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Temozolomide, business.industry, Standard treatment, Context (language use), General Medicine, medicine.disease, Lynch syndrome, Pituitary adenoma, Internal medicine, Glioma, Pituitary carcinoma, medicine, Carcinoma, Surgery, Neurology (clinical), business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::358199f4cdc28194ce36b9bf2b22518eTest
https://doi.org/10.1080/02688697.2021.1967881Test

4

Immune-checkpoint inhibitors in pituitary malignancies

المؤلفون: Alicia Tosoni, Stefania Bartolini, Raffaele Lodi, Vincenzo Di Nunno, Alba A. Brandes, Ilaria Maggio, Lidia Gatto, Enrico Franceschi

المساهمون: Di Nunno Vincenzo, Franceschi Enrico, Tosoni Alicia, Gatto Lidia, Maggio Ilaria, Lodi Raffaele, Bartolini Stefania, Brandes Alba A

المصدر: Anti-Cancer Drugs. 33:e28-e35

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Adenoma, Immune checkpoint inhibitors, medicine.medical_treatment, Ipilimumab, Pembrolizumab, Antibodies, Monoclonal, Humanized, immune-checkpoint inhibitorsipilimumabnivolumabpituitary adenomapituitary carcinoma, Adrenocorticotropic Hormone, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Tumor Microenvironment, medicine, Humans, Pituitary Neoplasms, Pharmacology (medical), In patient, Neoplasm Metastasis, Immune Checkpoint Inhibitors, Pharmacology, business.industry, medicine.disease, Radiation therapy, Nivolumab, Growth Hormone, Pituitary carcinoma, business, hormones, hormone substitutes, and hormone antagonists, medicine.drug

وصف الملف: ELETTRONICO

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4dbfdd10a46e54c1f83d0db7beb213b4Test
https://doi.org/10.1097/cad.0000000000001157Test

5

Synergism of Checkpoint Inhibitors and Peptide Receptor Radionuclide Therapy in the Treatment of Pituitary Carcinoma

المؤلفون: Viviane Tabar, Eliza B Geer, Lisa Bodei, Vasilisa A. Rudneva, Marc Cohen, Marc Rosenblum, Robert J. Young, John J. Cuaron, T. Jonathan Yang, Andrew L. Lin

المصدر: Journal of the Endocrine Society

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::616785807bb7540c7bbf3ed2d0ce183aTest
https://doi.org/10.1210/jendso/bvab133Test

6

Adrenocorticotropic Hormone Secreting Pituitary Carcinoma: Rare, Durable Response to Concurrent Chemotherapy and Reirradiation With a Review of the Literature

المؤلفون: Katherine Albano, Nathan T. Zwagerman, Joseph Bovi, Megan Orr, Jennifer Connelly, James W. Findling

المصدر: Advances in Radiation Oncology, Vol 7, Iss 2, Pp 100813-(2022)
Advances in Radiation Oncology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5be1b4b9be78469be548fa0a9450786dTest
http://www.sciencedirect.com/science/article/pii/S2452109421001718Test

7

Approach to the Treatment of a Patient with an Aggressive Pituitary Tumor

المؤلفون: Eliza B Geer, Viviane Tabar, T. Jonathan Yang, Lisa Bodei, Mark T.A. Donoghue, Sharon L. Wardlaw, Andrew L. Lin

المصدر: J Clin Endocrinol Metab

مصطلحات موضوعية: Adenoma, Oncology, medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, Immune checkpoint inhibitors, medicine.medical_treatment, Clinical Biochemistry, 030209 endocrinology & metabolism, Biochemistry, Neurosurgical Procedures, 03 medical and health sciences, 0302 clinical medicine, Endocrinology, Internal medicine, medicine, Humans, Neoplasm Invasiveness, Pituitary Neoplasms, Objective response, Chemotherapy, Temozolomide, business.industry, Biochemistry (medical), Pituitary tumors, Chemoradiotherapy, Adjuvant, Middle Aged, medicine.disease, Radiation therapy, Treatment Outcome, Drug Resistance, Neoplasm, Median time, 030220 oncology & carcinogenesis, Pituitary carcinoma, Approaches to the Patient, Female, Neoplasm Recurrence, Local, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::463910c700e6636781e0ca27904aa13aTest
https://doi.org/10.1210/clinem/dgaa649Test

8

Multimodal therapy in aggressive pituitary tumors

المؤلفون: Víctor Rodríguez Berrocal, Juan Jose Diez, Rosa Magallón, Héctor Pian, Pedro Iglesias, Mercedes Mitjavila

المصدر: Endocrinología, Diabetes y Nutrición. 67:469-485

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::464650a7b58e29f88cadc31a9d7a6ca2Test
https://doi.org/10.1016/j.endinu.2019.08.004Test

9

Immunotherapy for Aggressive and Metastatic Pituitary Neuroendocrine Tumors (PitNETs): State-of-the Art

المؤلفون: Tiziana Feola, Francesca Carbonara, Monica Verrico, Rosa Maria Di Crescenzo, Francesca Gianno, Claudio Colonnese, Antonietta Arcella, Dario de Alcubierre, Silverio Tomao, Vincenzo Esposito, Felice Giangaspero, Giuseppe Minniti, Marie-Lise Jaffrain-Rea

مصطلحات موضوعية: Cancer Research, tumor mutational burden, aggressive pituitary tumors, pituitary carcinoma, pituitary neuroendocrine tumors (PitNETs), temozolomide, radiotherapy, PDL1, immune checkpoint inhibitors, mismatch repair, immune-related adverse effects, case report, Oncology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfdbcb775b28e484b55ee497879e0740Test
http://hdl.handle.net/11697/192264Test

10

Aggressive pituitary tumours and pituitary carcinomas

المؤلفون: Thierry Brue, Hélène Lasolle, Vincent Amodru, Jacqueline Trouillas, Mirela Diana Ilie, Gérald Raverot, Frederic Castinetti

المساهمون: Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Hospices Civils de Lyon (HCL), Marseille medical genetics - Centre de génétique médicale de Marseille (MMG), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut Marseille Maladies Rares (MarMaRa), Aix Marseille Université (AMU), Service d'endocrinologie, diabète, maladies métaboliques [Hôpital de la Conception - APHM], Université de Lyon

المصدر: Nature Reviews Endocrinology
Nature Reviews Endocrinology, 2021, 17 (11), pp.671-684. ⟨10.1038/s41574-021-00550-w⟩

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61532d142f91bc4789374aaa87483b1dTest
https://hal-amu.archives-ouvertes.fr/hal-03662871Test

تنقيح النتائج